CellaVision
Growth and regained momentum in APAC
MAR
Organic sales growth:
Q3, 2023: 11% (-3)
EBITDA margin:
Q3, 2023: 26% (21)
July 1-September 30, 2023
- Net sales increased by 19% to SEK 168 m (141).
- Sales increased organically by 11% (-3), currency effect 8%.
- EBITDA amounted to SEK 43 m (29).
- EBITDA margin amounted to 26% (21).
- Profit before tax amounted to SEK 32 m (13).
- Earnings per share before and after dilution amounted to SEK 1.09 (0.44).
- Cash flow from operating activities amounted to SEK 73 m (31).
Datum | 2023-10-25, kl 07:20 |
Källa | MFN |
![](https://static.allaaktier.se/ads/hand-waving-2.png)